ME

Medpace Holdings Inc (MEDP)

HealthcareDiagnostics & Research
426.79USD
-0.60%
Magic Rank
#737
Earnings Yield
2.8%
Return on Capital
> 999%
Market Cap
16.7B

Performance vs S&P 500 (5Y)

MEDP.US
S&P 500

About Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Magic Formula Analysis

Enterprise Value16B
Market / Universe
us
USA

"A company with high ROC and high EY is statistically more likely to outperform the market."

Key Indicators

P/E Ratio41.32
Dividend YieldN/A
Debt to Equity-0.78
Gross Margin21.5%